Evidence map›Paper›PMID 30235201›Full record

ArticlePLoS biology2018

Aging alters the epigenetic asymmetry of HSC division.

M Carolina Florian, Markus Klose, Mehmet Sacma, Jelena Jablanovic, Luke Knudson, Kalpana J Nattamai, Gina Marka, Angelika Vollmer, Karin Soller, Vadim Sakk and 5 more

Abstract read
In one paragraph

Article in PLoS biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 104 papers.

0numbers the graph read from it
0cells of the map it votes in
104citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

104 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review

44 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

M Carolina FlorianInstitute of Molecular Medicine and Stem Cell Aging, University of Ulm, Ulm, Germany.ORCID 0000-0002-5791-1310
Markus KloseInstitute for Medical Informatics and Biometry, Carl Gustav Carus Faculty of Medicine, Technische Universität Dresden, Dresden, Germany.
Mehmet SacmaInstitute of Molecular Medicine and Stem Cell Aging, University of Ulm, Ulm, Germany.
Jelena JablanovicMax Planck Institute (MPI) of Immunobiology and Epigenetics, Freiburg, Germany.
Luke KnudsonInstitute of Molecular Medicine and Stem Cell Aging, University of Ulm, Ulm, Germany.
Kalpana J NattamaiDivision of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, Ohio, United States of America.
Gina MarkaInstitute of Molecular Medicine and Stem Cell Aging, University of Ulm, Ulm, Germany.
Angelika VollmerInstitute of Molecular Medicine and Stem Cell Aging, University of Ulm, Ulm, Germany.
Karin SollerInstitute of Molecular Medicine and Stem Cell Aging, University of Ulm, Ulm, Germany.
Vadim SakkInstitute of Molecular Medicine and Stem Cell Aging, University of Ulm, Ulm, Germany.
Nina Cabezas-WallscheidMax Planck Institute (MPI) of Immunobiology and Epigenetics, Freiburg, Germany.
Yi ZhengDivision of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, Ohio, United States of America.
Medhanie A MulawInstitute of Experimental Cancer Research, Medical Faculty, University of Ulm, Ulm, Germany.
Ingmar GlaucheInstitute for Medical Informatics and Biometry, Carl Gustav Carus Faculty of Medicine, Technische Universität Dresden, Dresden, Germany.
Hartmut GeigerInstitute of Molecular Medicine and Stem Cell Aging, University of Ulm, Ulm, Germany.

Funding

Leukemia stem cell polarity and differentiation therapyR01CA204895 · NCI · CINCINNATI CHILDRENS HOSP MED CTR · PI MULLOY, JAMES C, ZHENG, YI · 2017 to 2021
$2.2M
Cdc42, hematopoietic stem cell polarity, and cell fateR01DK104814 · NIDDK · CINCINNATI CHILDRENS HOSP MED CTR · PI ZHENG, YI · 2016 to 2019
$2.0M
Lineage Determination and Tissue HomeOstasis in the aged Hematopoietic SystemR01AG040118 · NIA · CINCINNATI CHILDRENS HOSP MED CTR · PI GEIGER, HARTMUT, ZHENG, YI · 2011 to 2015
$1.7M
Blood stem cell aging and biomarker studiesR01HL134617 · NHLBI · CINCINNATI CHILDRENS HOSP MED CTR · PI GEIGER, HARTMUT, ZHENG, YI · 2016 to 2019
$1.6M
NCI NIH HHS R01 CA204895NHLBI NIH HHS R01 HL134617NIA NIH HHS R01 AG040118NIDDK NIH HHS R01 DK104814
6 · The paper itself

Abstract

Hematopoietic stem cells (HSCs) balance self-renewal and differentiation to maintain homeostasis. With aging, the frequency of polar HSCs decreases. Cell polarity in HSCs is controlled by the activity of the small RhoGTPase cell division control protein 42 (Cdc42). Here we demonstrate-using a comprehensive set of paired daughter cell analyses that include single-cell 3D confocal imaging, single-cell transplants, single-cell RNA-seq, and single-cell transposase-accessible chromatin sequencing (ATAC-seq)-that the outcome of HSC divisions is strongly linked to the polarity status before mitosis, which is in turn determined by the level of the activity Cdc42 in stem cells. Aged apolar HSCs undergo preferentially self-renewing symmetric divisions, resulting in daughter stem cells with reduced regenerative capacity and lymphoid potential, while young polar HSCs undergo preferentially asymmetric divisions. Mathematical modeling in combination with experimental data implies a mechanistic role of the asymmetric sorting of Cdc42 in determining the potential of daughter cells via epigenetic mechanisms. Therefore, molecules that control HSC polarity might serve as modulators of the mode of stem cell division regulating the potential of daughter cells.

Indexed as

Epigenesis, GeneticAgingAnimalsAsymmetric Cell DivisionBone Marrow Cellscdc42 GTP-Binding ProteinCell AggregationCell DivisionCell LineageCell PolarityCellular SenescenceChromatinHematopoietic Stem CellsMice, Inbred C57BLTranscriptomeWnt-5a Proteincdc42 GTP-Binding ProteinChromatinWnt-5a Protein

Identifiers

PMID30235201
PMCPMC6168157

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.